Status:
ReviewerMember since: 2021
Organization: University Health Network
Great stability.
Application Area: cfDNA in oncology clinical trials
"The tubes are easy to use. Quite expensive, but produce reliable results and provide enhanced sample stability that is not available in other tubes."
Manufacturer's ResponseThank you for your review of our product and providing us with valuable feedback. It is our mission to support the important work our customers do and to meet their expectations in sales, service and support. For your unmet expectations, please reach out to our Product Manager Joel at jlechner@streck.com to discuss your work and feedback on your experience.
Status:
ReviewerMember since: 2020
Organization: RGCC S.A.
Great choice
Application Area:Cell-free DNA tubes
"The product was easy to use and we did not have any difficulty. Also the after service was excellent as everything we needed our supplier provided. The price of the product is value for money 100%"
Status:
ReviewerMember since: 2020
Organization: Prostate Cancer Clinical Trials Consortium
Fantastic product with clear advantage over other blood collection tubes.
Application Area:Analysis of circulating tumor cells (CTCs) and cell-free DNA (cfDNA) in prostate cancer patients
"Streck cell-free DNA BCT tubes are consistent in their quality and performance in producing accurate and trustworthy results from each assay that is performed following blood collection. The Streck cell-free DNA BCT offers a clear advantage over other blood collection tubes with its ability to stabilize cfDNA at room temperature for up to 14 days."
Status:
ReviewerMember since: 2020
Organization: Lab Genomics
Great tubes, love to use them for sample collection.
Application Area:Tumor cell gene variant analysis
"We achieve high quality results. sample preservation is excellent."
Cell-Free DNA BCT is a direct draw blood collection tube which stabilizes nucleated blood cells. The unique preservative limits the release of genomic DNA, allowing isolation of high-quality cell-free DNA. Cell-Free DNA BCT has also been demonstrated to minimize the degradation of circulating tumor cells (CTCs). By limiting cell lysis, the specialized chemistry provides sample integrity during storage, shipping and handling of blood samples. Cell-free DNA and gDNA are stable for up to 14 days at 6 °C to 37 °C. CTCs are stable for up to 7 days at 15 °C to 30 °C.
Cell-Free DNA BCT eliminates the need for immediate plasma preparation and CTC processing, allowing for convenient transportation from the collection site to a centralized testing location or reference lab for analysis.
Features
Benefits
Cell-Free DNA BCT is cleared by the US Food and Drug Administration (FDA)*. CE marked or Research Use Only (RUO) versions are also available, depending on location. For more information on availability in your region, please contact Streck or visit Streck.com.
*Performance characteristics of this device have only been established on the Guardant360 CDx assay.